Want to see GPCR full AI Analyst Report?
ETFs with Structure Therapeutics, Inc. Sponsored ADR (GPCR) Exposure
The following ETFs maintain exposure to Structure Therapeutics, Inc. Sponsored ADR (GPCR). ETF holdings data are updated periodically, based on the latest holdings the ETFs report, and are subject to change. To see a complete breakdown of any of the ETFs included in the table below, including asset class, AUM, and country allocations, click on the ticker symbol.
21 ETFs Hold Structure Therapeutics, Inc. Sponsored ADR (GPCR)
| Symbol | ETF Name | AUM | Expense Ratio | % Weight in ETF | Market Value | % Weight in GPCR |
|---|---|---|---|---|---|---|
| THNR | Amplify Weight Loss Drug & Treatment ETF | $5.83M | 0.59% | 2.30% | $133.79K | <0.01% |
| LRNZ | TrueShares Technology, AI & Deep Learning ETF | $43.66M | 0.69% | 1.84% | $757.45K | 0.05% |
| OZEM | Roundhill GLP-1 & Weight Loss ETF | $55.57M | 0.59% | 1.76% | $977.12K | 0.06% |
| WDNA | WisdomTree BioRevolution Fund | $5.18M | 0.45% | 1.08% | $54.46K | <0.01% |
| WDNA | WisdomTree BioRevolution UCITS ETF AccumUSD | $52.82M | 0.46% | 1.05% | $456.55K | 0.03% |
| SBIO | ALPS Medical Breakthroughs ETF | $187.80M | 0.50% | 1.04% | $1.91M | 0.12% |
| BBC | Virtus LifeSci Biotech Clinical Trials ETF | $35.24M | 0.65% | 0.40% | $136.14K | <0.01% |
| FMED | Fidelity Disruptive Medicine ETF | $54.39M | 0.50% | 0.32% | $175.52K | 0.01% |
| FDG | American Century Focused Dynamic Growth ETF | $428.98M | 0.45% | 0.29% | $1.24M | 0.06% |
| CCUS | Counterpoint Global CIBC U.S. Small Cap Growth ETF Trust Units | $3.36M | ― | 0.25% | $8,503.17 | <0.01% |
| FFSM | Fidelity US Fundamental Small-Mid Cap UCITS ETF AccumUSD | ― | 0.50% | 0.14% | $29.06K | <0.01% |
| FFSM | Fidelity Fundamental Small-Mid Cap ETF | $1.51B | 0.43% | 0.14% | $2.24M | 0.07% |
| OM3E | iShares NASDAQ US Biotechnology UCITS ETF | $78.53M | 0.37% | 0.11% | $1.53M | 0.10% |
| IBBQ | Invesco Nasdaq Biotechnology ETF | $120.43M | 0.19% | 0.11% | $137.65K | <0.01% |
| IBB | iShares Biotechnology ETF | $11.52B | 0.44% | 0.09% | $10.54M | 0.68% |
| APFO | iShares Asia Pacific AC ex-Japan Foreign Focus UCITS ETF Accum Shs - USD | $4.65M | 0.38% | 0.07% | $3,302.37 | <0.01% |
| GXC | SPDR S&P China ETF | $420.87M | 0.59% | 0.04% | $183.33K | 0.01% |
| APIE | ActivePassive International Equity ETF | $1.13B | 0.45% | 0.02% | $176.75K | 0.01% |
| SPEM | SPDR Portfolio Emerging Markets ETF | $16.38B | 0.07% | 0.01% | $1.83M | 0.12% |
| MSSM | Morgan Stanley Pathway Small-Mid Cap Equity ETF | $708.38M | 0.62% | <0.01% | $49.94K | <0.01% |
| ONEQ | Fidelity Nasdaq Composite Index ETF | $10.76B | 0.21% | <0.01% | $460.94K | 0.03% |
| Symbol | % Weight in ETF | ETF Name | AUM | Expense Ratio | Market Value | % Weight in GPCR |
|---|---|---|---|---|---|---|
| THNR | 2.30% | Amplify Weight Loss Drug & Treatment ETF | $5.83M | 0.59% | $133.79K | <0.01% |
| LRNZ | 1.84% | TrueShares Technology, AI & Deep Learning ETF | $43.66M | 0.69% | $757.45K | 0.05% |
| OZEM | 1.76% | Roundhill GLP-1 & Weight Loss ETF | $55.57M | 0.59% | $977.12K | 0.06% |
| WDNA | 1.08% | WisdomTree BioRevolution Fund | $5.18M | 0.45% | $54.46K | <0.01% |
| WDNA | 1.05% | WisdomTree BioRevolution UCITS ETF AccumUSD | $52.82M | 0.46% | $456.55K | 0.03% |
| SBIO | 1.04% | ALPS Medical Breakthroughs ETF | $187.80M | 0.50% | $1.91M | 0.12% |
| BBC | 0.40% | Virtus LifeSci Biotech Clinical Trials ETF | $35.24M | 0.65% | $136.14K | <0.01% |
| FMED | 0.32% | Fidelity Disruptive Medicine ETF | $54.39M | 0.50% | $175.52K | 0.01% |
| FDG | 0.29% | American Century Focused Dynamic Growth ETF | $428.98M | 0.45% | $1.24M | 0.06% |
| CCUS | 0.25% | Counterpoint Global CIBC U.S. Small Cap Growth ETF Trust Units | $3.36M | ― | $8,503.17 | <0.01% |
| FFSM | 0.14% | Fidelity US Fundamental Small-Mid Cap UCITS ETF AccumUSD | ― | 0.50% | $29.06K | <0.01% |
| FFSM | 0.14% | Fidelity Fundamental Small-Mid Cap ETF | $1.51B | 0.43% | $2.24M | 0.07% |
| OM3E | 0.11% | iShares NASDAQ US Biotechnology UCITS ETF | $78.53M | 0.37% | $1.53M | 0.10% |
| IBBQ | 0.11% | Invesco Nasdaq Biotechnology ETF | $120.43M | 0.19% | $137.65K | <0.01% |
| IBB | 0.09% | iShares Biotechnology ETF | $11.52B | 0.44% | $10.54M | 0.68% |
| APFO | 0.07% | iShares Asia Pacific AC ex-Japan Foreign Focus UCITS ETF Accum Shs - USD | $4.65M | 0.38% | $3,302.37 | <0.01% |
| GXC | 0.04% | SPDR S&P China ETF | $420.87M | 0.59% | $183.33K | 0.01% |
| APIE | 0.02% | ActivePassive International Equity ETF | $1.13B | 0.45% | $176.75K | 0.01% |
| SPEM | 0.01% | SPDR Portfolio Emerging Markets ETF | $16.38B | 0.07% | $1.83M | 0.12% |
| MSSM | <0.01% | Morgan Stanley Pathway Small-Mid Cap Equity ETF | $708.38M | 0.62% | $49.94K | <0.01% |
| ONEQ | <0.01% | Fidelity Nasdaq Composite Index ETF | $10.76B | 0.21% | $460.94K | 0.03% |
Popular ETF Comparisons
GPCR ETF Exposure FAQ
What ETFs hold Structure Therapeutics, Inc. Sponsored ADR stock?
Structure Therapeutics, Inc. Sponsored ADR (GPCR) is currently held by 21 ETFs in TipRanks’ ETF exposure database. The ETF(s) with exposure to GPCR include ALPS (SBIO), American Century (FDG) and Roundhill (OZEM).
Which ETF has the largest exposure to GPCR?
The ETF with the largest exposure to GPCR is ALPS (SBIO), with approximately $1.91M in market value exposure.
How much GPCR stock is held by ETFs?
ETFs currently hold approximately $5.85M worth of Structure Therapeutics, Inc. Sponsored ADR (GPCR) stock, based on TipRanks’ ETF exposure data.
How often is ETF exposure data updated?
ETF exposure data is updated periodically based on the latest available ETF holdings and reporting data. Actual ETF positions may change between reporting periods.
